You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PLOS this week: computational strategy to study human population histories, BRAF mutational load in melanoma and disease progression, and more.
Florida bill to bar life, disability, and long-term care insurers from using genetic information in coverage decisions poised to become law, according to Florida Politics.
CNN describes how Seegene in South Korea quickly developed and manufactured a test for SARS-CoV-2.
A New Jersey assemblyperson is considering a bill that would make DNA test results personal property, WHYY reports.
In Science this week: rare NOTCH signaling pathway mutations drive many head and neck squamous cell carcinomas, and more.
Holden Thorp, the editor-in-chief of Science, has penned an editorial criticizing President Donald Trump's distortion of science in the time of COVID-19.
Labs running or developing tests to detect SARS-CoV-2 infections are running into reagent and other bottlenecks, as Politico and GenomeWeb report.
With its new budget package, the UK plans to establish a DARPA-like research agency, the Guardian reports.
In Nature this week: new and efficient CRISPR system, chromatin interaction profiles improves prediction of brain disorder risk genes, and more.
Even if their doctors request it, people may not get tested for SARS-CoV-2 because of limited capacity, NPR reports.
NIH Director Francis Collins describes at Forbes how the agency is working with the Bill & Melinda Gates Foundation to develop gene-based treatments for sickle cell disease and HIV for sub-Saharan Africa.
The Hill reports PhRMA has closed its headquarters for the week to clean following after a visitor tested positive for SAR-CoV-2.
In Genome Research this week: approach to isolate viral genomes from metagenomic sequence collections, regulatory shifts in individuals with autism spectrum disorder, and more.
BBC News reports on a sequencing effort to track SARS-CoV-2 infections and uncover any co-infections.
Discover magazine writes that any resurrected mammoths might not really reflect how mammoths used to be.
Two publishers are testing new approaches to open access, according to Science.
In PNAS this week: role for MEN1 in pancreatic stress response, analysis of B immune cell response to yellow fever vaccine, and more.
According to the Seattle Times, the Bill & Melinda Gates Foundation is to enable home testing kits for SARS-CoV-2 to the Seattle area.
USA Today reports the Department of Justice issued a final rule that will enable the wider collection of DNA from individuals in federal immigration custody.
The Deseret News reports that a rapid DNA sequencing project to diagnose sick infants has begun in Utah.
In PLOS this week: genomic epidemiological features of dengue virus in Guangdong, analysis of ancient plaque give insight into past diets, and more.
NPR reports that a Seattle lab is ready to run hundreds or even thousands of tests for SARS-CoV-2.
The Sydney Morning Herald reports that scientists were able to stop a Klebsiella outbreak before it took hold through sequencing.
A survey of Finnish dog owner finds many dogs have problematic behaviors that could have genetic ties, according to Scientific American.
In Science this week: single-cell RNA sequencing approach to study mRNA synthesis and degradation rates, atlas of protein-coding genes in human, pig, and mouse brains, and more.
New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.
A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.
Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.
In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.